Full List of Protein(s) Regulated by This Metabolite |
Actin (ACT) |
Nesprin-2 (SYNE2) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
SYNE2 protein abundance levels: decrease (FC = 0.70) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the decrease of SYNE2 protein abundance compared with control group. |
Utrophin (UTRN) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
UTRN protein abundance levels: decrease (FC = 0.72) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the decrease of UTRN protein abundance compared with control group. |
Acyl-CoA binding (ACB) |
Bromodomain-containing protein 1 (BRD1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
BRD1 protein abundance levels: increase (FC = 11.11) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of BRD1 protein abundance compared with control group. |
ADP-ribosylation factor (Arf) |
ADP-ribosylation factor 1 (ARF1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
ARF1 protein abundance levels: decrease (FC = 0.63) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the decrease of ARF1 protein abundance compared with control group. |
ADP-ribosylation factor 6 (ARF6) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
ARF6 protein abundance levels: increase (FC = 1.65) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of ARF6 protein abundance compared with control group. |
ADP-ribosylation factor-like 1 (ARL1) |
Click to Show/Hide the Full List of Regulating Pair(s): 2 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair (1) |
Experim Info
click to show the details of experiment for validating this pair
|
[2] |
Introduced Variation |
Glutamine addition (12 hours) |
Induced Change |
ARL1 protein expression levels: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that glutamine addition causes the decrease of ARL1 protein expression compared with control group. |
Regulating Pair (2) |
Experim Info
click to show the details of experiment for validating this pair
|
[2] |
Introduced Variation |
Glutamine addition (12 hours) |
Induced Change |
ARL1 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Inflammatory bowel disease [ICD-11: DD72]
|
Details |
It is reported that glutamine addition causes the increase of ARL1 protein expression compared with control group. |
Amoebapore (AMB) |
Prosaposin (PSAP) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
PSAP protein abundance levels: increase (FC = 1.80) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of PSAP protein abundance compared with control group. |
Annexin (ANEX) |
Annexin A3 (ANXA3) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glutamine addition (24 hours) |
Induced Change |
ANXA3 protein expression levels: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that glutamine addition causes the decrease of ANXA3 protein expression compared with control group. |
Apolipoprotein (Apo) |
Apolipoprotein A-I (APOA1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[4] |
Introduced Variation |
Glutamine addition (576 hours) |
Induced Change |
APOA1 protein expression levels: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that glutamine addition causes the decrease of APOA1 protein expression compared with control group. |
cDNA FLJ55764 |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
cDNA FLJ55764, highly similar to Apolipoprotein-L2 protein abundance levels: increase (FC = 1.51) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of cDNA FLJ55764, highly similar to Apolipoprotein-L2 protein abundance compared with control group. |
Armet (ART) |
cDNA FLJ77177 |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
cDNA FLJ77177, highly similar to Homo sapiens arginine-rich, mutated in early stage tumors (FC = 1.59) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of cDNA FLJ77177, highly similar to Homo sapiens arginine-rich, mutated in early stage tumors (ARMET), mRNA protein abundance compared with control group. |
Autophagy protein (Auto) |
Autophagy protein 5 (ATG5) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glutamine addition (24 hours) |
Induced Change |
ATG5 protein expression levels: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that glutamine addition causes the decrease of ATG5 protein expression compared with control group. |
MAP1 light chain 3-like protein 2 (MAP1LC3B) |
Click to Show/Hide the Full List of Regulating Pair(s): 2 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair (1) |
Experim Info
click to show the details of experiment for validating this pair
|
[5] |
Introduced Variation |
Glutamine addition (24 hours) |
Induced Change |
MAP1LC3B protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Sepsis [ICD-11: 1G40]
|
Details |
It is reported that glutamine addition causes the increase of MAP1LC3B protein expression compared with control group. |
Regulating Pair (2) |
Experim Info
click to show the details of experiment for validating this pair
|
[5] |
Introduced Variation |
Glutamine addition (24 hours) |
Induced Change |
MAP1LC3B protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Sepsis [ICD-11: 1G40]
|
Details |
It is reported that glutamine addition causes the increase of MAP1LC3B protein expression compared with control group. |
Beta-catenin-interacting protein (BCIP) |
Beta catenin interacting 1 (CTNNBIP1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glutamine addition (24 hours) |
Induced Change |
CTNNBIP1 protein expression levels: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that glutamine addition causes the decrease of CTNNBIP1 protein expression compared with control group. |
Calcium-binding protein (CBP) |
Reticulocalbin-1 (RCN1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[4] |
Introduced Variation |
Glutamine addition (576 hours) |
Induced Change |
RCN1 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that glutamine addition causes the increase of RCN1 protein expression compared with control group. |
Calmodulin (Calmo) |
Calmodulin 2 (CALM2) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
CALM2 protein abundance levels: increase (FC = 2.19) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of CALM2 protein abundance compared with control group. |
Cell death regulator (CDR) |
Cell death regulator Aven (AVEN) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glutamine addition (24 hours) |
Induced Change |
AVEN protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that glutamine addition causes the increase of AVEN protein expression compared with control group. |
Centromere protein (CenP) |
Centromere protein V (CENPV) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
CENPV protein abundance levels: increase (FC = 1.93) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of CENPV protein abundance compared with control group. |
Ceroid-lipofuscinosis neuronal protein (CLN) |
Ceroid-lipofuscinosis neuronal 6 (CLN6) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
CLN6 protein abundance levels: increase (FC = 1.71) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of CLN6 protein abundance compared with control group. |
Chaperone protein (ChaP) |
Chaperonin containing TCP1 alpha (CCT1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[4] |
Introduced Variation |
Glutamine addition (576 hours) |
Induced Change |
TCP1 protein expression levels: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that glutamine addition causes the decrease of TCP1 protein expression compared with control group. |
DnaJ homolog subfamily C member 8 (DNAJC8) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
DNAJC8 protein abundance levels: decrease (FC = 0.77) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the decrease of DNAJC8 protein abundance compared with control group. |
Chloroplast envelope erotein translocase (CEPT) |
TP53-regulated inhibitor of apoptosis 1 (TRIAP1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glutamine addition (24 hours) |
Induced Change |
TRIAP1 protein expression levels: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that glutamine addition causes the decrease of TRIAP1 protein expression compared with control group. |
Chromobox protein (ChrBP) |
Chromobox protein homolog 3 (CBX3) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[4] |
Introduced Variation |
Glutamine addition (576 hours) |
Induced Change |
CBX3 protein expression levels: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that glutamine addition causes the decrease of CBX3 protein expression compared with control group. |
Clathrin (CLA) |
Clathrin light chain A (CLTA) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
CLTA protein abundance levels: increase (FC = 1.41) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of CLTA protein abundance compared with control group. |
Claudin tight junction (Clau) |
Claudin-1 (CLDN1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[6] |
Introduced Variation |
Glutamine decrease (504 hours) |
Induced Change |
CLDN1 protein expression levels: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that glutamine decrease causes the decrease of CLDN1 protein expression compared with control group. |
Coiled-coil containing (CCC) |
BAT2-containing protein 1 (BAT2D1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
PRRC2C protein abundance levels: increase (FC = 1.41) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of PRRC2C protein abundance compared with control group. |
cDNA FLJ51028 |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
cDNA FLJ51028, highly similar to 60 kDa heat shock protein, mitochondrial protein abundance levels: increase (FC = 1.72) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of cDNA FLJ51028, highly similar to 60 kDa heat shock protein, mitochondrial protein abundance compared with control group. |
DKFZP586J0619 protein (DKFZP586J0619) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
DKFZP586J0619 protein abundance levels: decrease (FC = 0.19) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the decrease of DKFZP586J0619 protein abundance compared with control group. |
Drug-sensitive protein 1 (YA61) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
YA61 protein abundance levels: decrease (FC = 0.71) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the decrease of YA61 protein abundance compared with control group. |
Exocyst complex component 5 (EXOC5) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
exocyst complex component 5 protein abundance levels: decrease (FC = 0.75) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the decrease of exocyst complex component 5 protein abundance compared with control group. |
Hydrocephalus-inducing protein homolog (HYDIN) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
HYDIN protein abundance levels: decrease (FC = 0.70) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the decrease of HYDIN protein abundance compared with control group. |
Intraflagellar transport 74 (IFT74) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glutamine addition (24 hours) |
Induced Change |
IFT74 protein expression levels: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that glutamine addition causes the decrease of IFT74 protein expression compared with control group. |
COMM domain containing (COMM) |
COMM domain-containing protein 2 (COMMD2) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glutamine addition (24 hours) |
Induced Change |
COMMD2 protein expression levels: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that glutamine addition causes the decrease of COMMD2 protein expression compared with control group. |
COMM domain-containing protein 6 (COMMD6) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glutamine addition (24 hours) |
Induced Change |
COMMD6 protein expression levels: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that glutamine addition causes the decrease of COMMD6 protein expression compared with control group. |
Corticotropin-releasing factor binding (CRFB) |
Corticotropin-releasing factor-binding (CRHBP) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[2] |
Introduced Variation |
Glutamine addition (12 hours) |
Induced Change |
CRHBP protein expression levels: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Inflammatory bowel disease [ICD-11: DD72]
|
Details |
It is reported that glutamine addition causes the decrease of CRHBP protein expression compared with control group. |
Cyclin-related protein (CRP) |
Caprin-1 (RNG105) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[7] |
Introduced Variation |
Glutamine decrease (48 hours) |
Induced Change |
CAPRIN1 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine decrease causes the increase of CAPRIN1 protein expression compared with control group. |
Cystatin (Cyst) |
Cystatin-A (CSTA) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[2] |
Introduced Variation |
Glutamine addition (12 hours) |
Induced Change |
CSTA protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Inflammatory bowel disease [ICD-11: DD72]
|
Details |
It is reported that glutamine addition causes the increase of CSTA protein expression compared with control group. |
Cytochrome (Cyt) |
Cytochrome B5 (MCB5) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
CYB5A protein abundance levels: increase (FC = 7.47) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of CYB5A protein abundance compared with control group. |
Cytochrome oxidase (CytOx) |
Cytochrome C oxidase 6B1 (COX6B1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
COX6B1 protein abundance levels: increase (FC = 2.39) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of COX6B1 protein abundance compared with control group. |
Cytochrome reductase (CytRe) |
Ubiquinol-cytochrome c reductase hinge protein (UQCRH) |
Click to Show/Hide the Full List of Regulating Pair(s): 2 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair (1) |
Experim Info
click to show the details of experiment for validating this pair
|
[2] |
Introduced Variation |
Glutamine addition (12 hours) |
Induced Change |
UQCRH protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Inflammatory bowel disease [ICD-11: DD72]
|
Details |
It is reported that glutamine addition causes the increase of UQCRH protein expression compared with control group. |
Regulating Pair (2) |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
UQCRH protein abundance levels: increase (FC = 1.79) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of UQCRH protein abundance compared with control group. |
Death-receptor fusion protein (DRF) |
Thyroid adenoma-associated protein (THADA) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
THADA protein abundance levels: decrease (FC = 0.71) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the decrease of THADA protein abundance compared with control group. |
Dispanin (DIP) |
Interferon-induced transmembrane protein 2 (IFITM2) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
IFITM2 protein abundance levels: increase (FC = 1.74) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of IFITM2 protein abundance compared with control group. |
DNA binding protein (DNBP) |
Cysteine/serine-rich nuclear 3 (CSRNP3) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[2] |
Introduced Variation |
Glutamine addition (12 hours) |
Induced Change |
CSRNP3 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Inflammatory bowel disease [ICD-11: DD72]
|
Details |
It is reported that glutamine addition causes the increase of CSRNP3 protein expression compared with control group. |
DEK protein (DEK) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
DEK protein abundance levels: decrease (FC = 0.74) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the decrease of DEK protein abundance compared with control group. |
Nuclear ubiquitous casein CDK substrate 1 (NUCKS1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
NUCKS1 protein abundance levels: increase (FC = 1.48) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of NUCKS1 protein abundance compared with control group. |
Nucleolar transcription factor 1 (UBTF) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
UBTF protein abundance levels: increase (FC = 1.38) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of UBTF protein abundance compared with control group. |
Dystroglycan (DYG) |
Dystroglycan (DAG1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
DAG1 protein abundance levels: decrease (FC = 0.76) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the decrease of DAG1 protein abundance compared with control group. |
EBNA binding protein (EBP) |
EBNA1-binding protein 2 (EBP2) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
EBNA1BP2 protein abundance levels: increase (FC = 1.34) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of EBNA1BP2 protein abundance compared with control group. |
EF-hand domain-containing (EHC) |
Calcium-dependent protease small 2 (CAPNS2) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[2] |
Introduced Variation |
Glutamine addition (12 hours) |
Induced Change |
CAPNS2 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Inflammatory bowel disease [ICD-11: DD72]
|
Details |
It is reported that glutamine addition causes the increase of CAPNS2 protein expression compared with control group. |
Endocytosis protein (Endo) |
Adaptin ear-binding protein 1 (NECAP1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
NECAP1 protein abundance levels: increase (FC = 1.49) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of NECAP1 protein abundance compared with control group. |
Ezrin-radixin-moesin (ERM) |
Tyrosine kinase activator protein 1 (TKA-1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
SLC9A3R2 protein abundance levels: increase (FC = 1.32) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of SLC9A3R2 protein abundance compared with control group. |
Ezrin/radixin/moesin-binding phosphoprotein (ERMP) |
Tight junction protein ZO-1 (TJP1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[6] |
Introduced Variation |
Glutamine decrease (0.5 hours) |
Induced Change |
TJP1 protein expression levels: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that glutamine decrease causes the decrease of TJP1 protein expression compared with control group. |
F-actin-capping protein (FACP) |
F-actin-capping alpha-1 (CAPZA1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
CAPZA1 protein abundance levels: increase (FC = 1.36) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of CAPZA1 protein abundance compared with control group. |
Fatty acid binding protein (FABP) |
Cellular retinoic acid-binding 1 (CRABP1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glutamine addition (24 hours) |
Induced Change |
CRABP1 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that glutamine addition causes the increase of CRABP1 protein expression compared with control group. |
Fatty acid-binding protein 1 (FABP1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[8] |
Introduced Variation |
Glutamine addition (5 hours) |
Induced Change |
FABP1 protein expression levels: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Inflammatory bowel disease [ICD-11: DD72]
|
Details |
It is reported that glutamine addition causes the decrease of FABP1 protein expression compared with control group. |
Retinol-binding protein 1 (RBP1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
RBP1 protein abundance levels: increase (FC = 2.74) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of RBP1 protein abundance compared with control group. |
Fibrinogen (FibGe) |
Fibrinogen (FGG) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[4] |
Introduced Variation |
Glutamine addition (576 hours) |
Induced Change |
FGG protein expression levels: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that glutamine addition causes the decrease of FGG protein expression compared with control group. |
G-protein alpha/beta/gamma complex (GPC) |
Transducin beta chain 1 (GNB1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
GNB1 protein abundance levels: increase (FC = 1.40) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of GNB1 protein abundance compared with control group. |
Transducin beta chain 2 (GNB2) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
GNB2 protein abundance levels: increase (FC = 1.62) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of GNB2 protein abundance compared with control group. |
General secretory pathway (SEC) |
Signal recognition particle 9 kDa protein (SRP9) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
SRP9 protein abundance levels: decrease (FC = 0.77) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the decrease of SRP9 protein abundance compared with control group. |
Glycine cleavage H (GCH) |
Glycine cleavage system H protein (GCSH) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
GCSH protein abundance levels: increase (FC = 1.50) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of GCSH protein abundance compared with control group. |
Golgi membrane protein (GMP) |
Golgin subfamily A member 3 (GOLGA3) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
GOLGA3 protein abundance levels: increase (FC = 1.31) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of GOLGA3 protein abundance compared with control group. |
Golgi reassembly-stacking protein (GORASP) |
cDNA FLJ54595 |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
cDNA FLJ54595, highly similar to Golgi reassembly-stacking protein 2 protein abundance levels: increase (FC = 1.33) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of cDNA FLJ54595, highly similar to Golgi reassembly-stacking protein 2 protein abundance compared with control group. |
GPCR rhodopsin (GPCR-1) |
Olfactory receptor 5AC2 (OR5AC2) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
OR5AC2 protein abundance levels: decrease (FC = 0.59) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the decrease of OR5AC2 protein abundance compared with control group. |
Guanine nucleotide binding protein (GNBP) |
G protein gamma 8 (GNG8) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glutamine addition (24 hours) |
Induced Change |
GNG8 protein expression levels: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that glutamine addition causes the decrease of GNG8 protein expression compared with control group. |
Histone (HST) |
Core histone macro-H2A.1 (H2AFY) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
MACROH2A1 protein abundance levels: increase (FC = 5.71) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of MACROH2A1 protein abundance compared with control group. |
Histone H2A type 1 (H2AC11) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
H2AC11 MORE protein abundance levels: increase (FC = 1.87) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of H2AC11 MORE protein abundance compared with control group. |
Histone H2B 1-C/E/F/G/I (H2BC4) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
H2BC4 MORE protein abundance levels: increase (FC = 2.04) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of H2BC4 MORE protein abundance compared with control group. |
Histone H4 (H4C1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
H4C1 MORE protein abundance levels: increase (FC = 1.38) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of H4C1 MORE protein abundance compared with control group. |
Hydrolases (EC 3) |
Aminoacylase-1 (ACY1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[8] |
Introduced Variation |
Glutamine addition (5 hours) |
Induced Change |
ACY1 protein expression levels: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Inflammatory bowel disease [ICD-11: DD72]
|
Details |
It is reported that glutamine addition causes the decrease of ACY1 protein expression compared with control group. |
Carboxylic ester hydrolase (CEH) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
carboxylic ester hydrolase protein abundance levels: increase (FC = 2.14) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of carboxylic ester hydrolase protein abundance compared with control group. |
Caspase recruitment domain-containing protein 9 (CARD9) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[2] |
Introduced Variation |
Glutamine addition (12 hours) |
Induced Change |
CARD9 protein expression levels: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Inflammatory bowel disease [ICD-11: DD72]
|
Details |
It is reported that glutamine addition causes the decrease of CARD9 protein expression compared with control group. |
Caspase-3 (CASP3) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glutamine addition (24 hours) |
Induced Change |
CASP3 protein expression levels: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that glutamine addition causes the decrease of CASP3 protein expression compared with control group. |
cDNA FLJ54622 |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
cDNA FLJ54622, highly similar to Prothrombin protein abundance levels: increase (FC = 1.47) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of cDNA FLJ54622, highly similar to Prothrombin protein abundance compared with control group. |
Choline phosphatase 3 (PLD3) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
PLD3 protein abundance levels: increase (FC = 1.32) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of PLD3 protein abundance compared with control group. |
Cytidine deaminase (CDA) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
CDA protein abundance levels: increase (FC = 1.64) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of CDA protein abundance compared with control group. |
Dehydropeptidase I (DPEP1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[2] |
Introduced Variation |
Glutamine addition (12 hours) |
Induced Change |
DPEP1 protein expression levels: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Inflammatory bowel disease [ICD-11: DD72]
|
Details |
It is reported that glutamine addition causes the decrease of DPEP1 protein expression compared with control group. |
Dual specificity protein phosphatase 1 (DUSP1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[9] |
Introduced Variation |
Glutamine addition (6 hours) |
Induced Change |
DUSP1 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Sepsis [ICD-11: 1G40]
|
Details |
It is reported that glutamine addition causes the increase of DUSP1 protein expression compared with control group. |
Endoribonuclease LACTB2 (LACTB2) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
LACTB2 protein abundance levels: decrease (FC = 0.71) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the decrease of LACTB2 protein abundance compared with control group. |
ER alpha-1,2-mannosidase (MAN1B1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
MAN1B1 protein abundance levels: decrease (FC = 0.75) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the decrease of MAN1B1 protein abundance compared with control group. |
Fructose-bisphosphatase (FBP1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
fructose-bisphosphatase protein abundance levels: increase (FC = 7.58) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of fructose-bisphosphatase protein abundance compared with control group. |
Gankyrin (PSMD10) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
PSMD10 protein abundance levels: increase (FC = 1.51) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of PSMD10 protein abundance compared with control group. |
GTP-binding protein 10 (GTPBP10) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
GTPBP10 protein abundance levels: decrease (FC = 0.72) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the decrease of GTPBP10 protein abundance compared with control group. |
Heat-responsive protein 12 (HRSP12) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
RIDA protein abundance levels: increase (FC = 8.02) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of RIDA protein abundance compared with control group. |
Helicase-like protein (SKIV2L) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
SKIV2L protein abundance levels: increase (FC = 1.30) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of SKIV2L protein abundance compared with control group. |
Inactive pantothenic acid kinase 4 (PANK4) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
4'-phosphopantetheine phosphatase protein abundance levels: decrease (FC = 0.76) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the decrease of 4'-phosphopantetheine phosphatase protein abundance compared with control group. |
Inosine triphosphate pyrophosphatase (ITPA) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[2] |
Introduced Variation |
Glutamine addition (12 hours) |
Induced Change |
ITPA protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Inflammatory bowel disease [ICD-11: DD72]
|
Details |
It is reported that glutamine addition causes the increase of ITPA protein expression compared with control group. |
Intraflagellar transport 27 (IFT27) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
IFT27 protein abundance levels: decrease (FC = 0.77) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the decrease of IFT27 protein abundance compared with control group. |
Kyphoscoliosis peptidase (KY) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
KY protein abundance levels: decrease (FC = 0.57) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the decrease of KY protein abundance compared with control group. |
L-glutamine amidohydrolase (GLS) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[7] |
Introduced Variation |
Glutamine decrease (48 hours) |
Induced Change |
GLS protein expression levels: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine decrease causes the decrease of GLS protein expression compared with control group. |
Matrix metalloproteinase-13 (MMP-13) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[2] |
Introduced Variation |
Glutamine addition (12 hours) |
Induced Change |
MMP13 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Inflammatory bowel disease [ICD-11: DD72]
|
Details |
It is reported that glutamine addition causes the increase of MMP13 protein expression compared with control group. |
Matrix metalloproteinase-7 (MMP-7) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[2] |
Introduced Variation |
Glutamine addition (12 hours) |
Induced Change |
MMP7 protein expression levels: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Inflammatory bowel disease [ICD-11: DD72]
|
Details |
It is reported that glutamine addition causes the decrease of MMP7 protein expression compared with control group. |
Omega-amidase NIT2 (NIT2) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
NIT2 protein abundance levels: increase (FC = 1.36) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of NIT2 protein abundance compared with control group. |
Peroxisomal leader processing protease (TYSND1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
TYSND1 protein abundance levels: increase (FC = 1.66) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of TYSND1 protein abundance compared with control group. |
Phosphodiesterase 4D (PDE4D) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
PDE4D protein abundance levels: decrease (FC = 0.49) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the decrease of PDE4D protein abundance compared with control group. |
Phosphoinositide phospholipase C-eta-1 (PLCH1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
PLCH1 protein abundance levels: decrease (FC = 0.75) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the decrease of PLCH1 protein abundance compared with control group. |
Phosphoserine phosphatase (PSPH) |
Click to Show/Hide the Full List of Regulating Pair(s): 2 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair (1) |
Experim Info
click to show the details of experiment for validating this pair
|
[7] |
Introduced Variation |
Glutamine decrease (48 hours) |
Induced Change |
PSPH protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cervical Cancer [ICD-11: 2C77]
... |
Details |
It is reported that glutamine decrease causes the increase of PSPH protein expression compared with control group. |
Regulating Pair (2) |
Experim Info
click to show the details of experiment for validating this pair
|
[7] |
Introduced Variation |
Glutamine decrease (48 hours) |
Induced Change |
PSPH mRNA levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cervical Cancer [ICD-11: 2C77]
... |
Details |
It is reported that glutamine decrease causes the increase of PSPH mRNA levels compared with control group. |
Proteasome component C2 (PSMA1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[2] |
Introduced Variation |
Glutamine addition (12 hours) |
Induced Change |
PSMA1 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Inflammatory bowel disease [ICD-11: DD72]
|
Details |
It is reported that glutamine addition causes the increase of PSMA1 protein expression compared with control group. |
Proteasome component C9 (PSMA4) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[2] |
Introduced Variation |
Glutamine addition (12 hours) |
Induced Change |
PSMA4 protein expression levels: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Inflammatory bowel disease [ICD-11: DD72]
|
Details |
It is reported that glutamine addition causes the decrease of PSMA4 protein expression compared with control group. |
Protein kinase C substrate 80K-H (PRKCSH) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glutamine addition (24 hours) |
Induced Change |
PRKCSH protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that glutamine addition causes the increase of PRKCSH protein expression compared with control group. |
Protein phosphatase 2 regulatory B gamma (PPP2R2C) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[2] |
Introduced Variation |
Glutamine addition (12 hours) |
Induced Change |
PPP2R2C protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Inflammatory bowel disease [ICD-11: DD72]
|
Details |
It is reported that glutamine addition causes the increase of PPP2R2C protein expression compared with control group. |
Protein-tyrosine phosphatase 1B (PTPN1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[2] |
Introduced Variation |
Glutamine addition (12 hours) |
Induced Change |
PTPN1 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Inflammatory bowel disease [ICD-11: DD72]
|
Details |
It is reported that glutamine addition causes the increase of PTPN1 protein expression compared with control group. |
Ras-related protein Rab-1B (RAB1B) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[2] |
Introduced Variation |
Glutamine addition (12 hours) |
Induced Change |
RAB1B protein expression levels: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Inflammatory bowel disease [ICD-11: DD72]
|
Details |
It is reported that glutamine addition causes the decrease of RAB1B protein expression compared with control group. |
Ras-related protein Rab-39A (RAB39A) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[2] |
Introduced Variation |
Glutamine addition (12 hours) |
Induced Change |
RAB39A protein expression levels: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Inflammatory bowel disease [ICD-11: DD72]
|
Details |
It is reported that glutamine addition causes the decrease of RAB39A protein expression compared with control group. |
Ras-related protein Rab-5B (RAB5B) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
RAB5B protein abundance levels: increase (FC = 1.45) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of RAB5B protein abundance compared with control group. |
Regucalcin (RGN) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
RGN protein abundance levels: increase (FC = 7.28) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of RGN protein abundance compared with control group. |
Septin-10 (SEPT10) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
SEPTIN10 protein abundance levels: decrease (FC = 0.63) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the decrease of SEPTIN10 protein abundance compared with control group. |
Serine beta-lactamase-like protein LACTB (MRPL56) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
LACTB protein abundance levels: increase (FC = 3.53) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of LACTB protein abundance compared with control group. |
Serine/threonine PP2A-alpha (PPP2CA) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
PPP2CA protein abundance levels: increase (FC = 1.36) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of PPP2CA protein abundance compared with control group. |
Trans-Golgi network integral membrane 2 (TGOLN2) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glutamine addition (24 hours) |
Induced Change |
TGOLN2 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that glutamine addition causes the increase of TGOLN2 protein expression compared with control group. |
Transforming protein RhoA (RHOA) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
RHOA protein abundance levels: increase (FC = 1.32) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of RHOA protein abundance compared with control group. |
Ubiquitin carboxyl-terminal hydrolase 19 (USP19) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
USP19 protein abundance levels: decrease (FC = 0.76) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the decrease of USP19 protein abundance compared with control group. |
Ubiquitin thioesterase L3 (UCHL3) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[2] |
Introduced Variation |
Glutamine addition (12 hours) |
Induced Change |
UCHL3 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Inflammatory bowel disease [ICD-11: DD72]
|
Details |
It is reported that glutamine addition causes the increase of UCHL3 protein expression compared with control group. |
Immunoglobulin (IMG) |
Roundabout homolog 1 (ROBO1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
ROBO1 protein abundance levels: increase (FC = 1.39) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of ROBO1 protein abundance compared with control group. |
Insulin-like growth factor binding protein (IGFBP) |
cDNA FLJ96197 |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
cDNA, FLJ96197, highly similar to Homo sapiens connective tissue growth factor (FC = 1.56) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of cDNA, FLJ96197, highly similar to Homo sapiens connective tissue growth factor (CTGF), mRNA protein abundance compared with control group. |
Integrin (IntG) |
cDNA FLJ60385 |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
cDNA FLJ60385, highly similar to Integrin alpha-3 protein abundance levels: increase (FC = 1.43) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of cDNA FLJ60385, highly similar to Integrin alpha-3 protein abundance compared with control group. |
Interleukin (IL) |
Interleukin-10 (IL10) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[10] |
Introduced Variation |
Glutamine addition (18 hours) |
Induced Change |
IL10 mRNAlevel levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Inflammatory bowel disease [ICD-11: DD72]
|
Details |
It is reported that glutamine addition causes the increase of IL10 mRNA levels compared with control group. |
Interleukin-18 (IL18) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[9] |
Introduced Variation |
Glutamine addition (6 hours) |
Induced Change |
IL18 protein expression levels: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Sepsis [ICD-11: 1G40]
|
Details |
It is reported that glutamine addition causes the decrease of IL18 protein expression compared with control group. |
Interleukin-6 (IL6) |
Click to Show/Hide the Full List of Regulating Pair(s): 2 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair (1) |
Experim Info
click to show the details of experiment for validating this pair
|
[10] |
Introduced Variation |
Glutamine addition (18 hours) |
Induced Change |
IL6 protein expression levels: decrease (FC = 1.2) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Inflammatory bowel disease [ICD-11: DD72]
|
Details |
It is reported that glutamine addition causes the decrease of IL6 protein expression compared with control group. |
Regulating Pair (2) |
Experim Info
click to show the details of experiment for validating this pair
|
[9] |
Introduced Variation |
Glutamine addition (6 hours) |
Induced Change |
IL6 protein expression levels: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Sepsis [ICD-11: 1G40]
|
Details |
It is reported that glutamine addition causes the decrease of IL6 protein expression compared with control group. |
Interleukin-8 (IL8) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[10] |
Introduced Variation |
Glutamine addition (18 hours) |
Induced Change |
CXCL8 protein expression levels: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Inflammatory bowel disease [ICD-11: DD72]
|
Details |
It is reported that glutamine addition causes the decrease of CXCL8 protein expression compared with control group. |
Intermediate filament (InFi) |
Cytokeratin-20 (KRT20) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[4] |
Introduced Variation |
Glutamine addition (576 hours) |
Induced Change |
KRT20 protein expression levels: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that glutamine addition causes the decrease of KRT20 protein expression compared with control group. |
Cytokeratin-9 (KRT9) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
KRT9 protein abundance levels: increase (FC = 1.49) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of KRT9 protein abundance compared with control group. |
Epithelial keratin-2e (KRT2) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
KRT2 protein abundance levels: decrease (FC = 0.64) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the decrease of KRT2 protein abundance compared with control group. |
Intracellular chloride channel (CLIC) |
Chloride intracellular channel protein (CLIC) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
chloride intracellular channel protein protein abundance levels: increase (FC = 1.35) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of chloride intracellular channel protein protein abundance compared with control group. |
Isomerases (EC 5) |
Galactose mutarotase (GALM) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
GALM protein abundance levels: increase (FC = 1.66) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of GALM protein abundance compared with control group. |
HUMAN FK506 binding protein 10 (FKBP10) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glutamine addition (24 hours) |
Induced Change |
FKBP10 protein expression levels: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that glutamine addition causes the decrease of FKBP10 protein expression compared with control group. |
Methylmalonyl-CoA epimerase (MCEE) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
MCEE protein abundance levels: increase (FC = 2.23) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of MCEE protein abundance compared with control group. |
Methylmalonyl-CoA mutase (MMUT) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
MMUT protein abundance levels: increase (FC = 1.55) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of MMUT protein abundance compared with control group. |
Phosphoglycerate mutase 1 (PGAM1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[7] |
Introduced Variation |
Glutamine decrease (48 hours) |
Induced Change |
PGAM1 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine decrease causes the increase of PGAM1 protein expression compared with control group. |
Prostaglandin E synthase 3 (PTGES3) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
PTGES3 protein abundance levels: increase (FC = 1.36) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of PTGES3 protein abundance compared with control group. |
Protein disulfide-isomerase A6 (PDIA6) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
PDIA6 protein abundance levels: increase (FC = 1.35) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of PDIA6 protein abundance compared with control group. |
Rotamase A (PPIA) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
PPIA protein abundance levels: increase (FC = 1.48) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of PPIA protein abundance compared with control group. |
Triosephosphate isomerase (TPI1) |
Click to Show/Hide the Full List of Regulating Pair(s): 2 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair (1) |
Experim Info
click to show the details of experiment for validating this pair
|
[2] |
Introduced Variation |
Glutamine addition (12 hours) |
Induced Change |
TPI1 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Inflammatory bowel disease [ICD-11: DD72]
|
Details |
It is reported that glutamine addition causes the increase of TPI1 protein expression compared with control group. |
Regulating Pair (2) |
Experim Info
click to show the details of experiment for validating this pair
|
[7] |
Introduced Variation |
Glutamine decrease (48 hours) |
Induced Change |
TPI1 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine decrease causes the increase of TPI1 protein expression compared with control group. |
Lectin (Lec) |
cDNA FLJ52117 |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
cDNA FLJ52117, highly similar to Oxidized low-density lipoprotein receptor 1 protein abundance levels: increase (FC = 1.64) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of cDNA FLJ52117, highly similar to Oxidized low-density lipoprotein receptor 1 protein abundance compared with control group. |
cDNA FLJ52285 |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
cDNA FLJ52285, highly similar to Vesicular integral-membrane protein VIP36 protein abundance levels: increase (FC = 1.31) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of cDNA FLJ52285, highly similar to Vesicular integral-membrane protein VIP36 protein abundance compared with control group. |
cDNA FLJ93313 |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
cDNA, FLJ93313, highly similar to Homo sapiens lectin, mannose-binding, 1 (FC = 1.33) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of cDNA, FLJ93313, highly similar to Homo sapiens lectin, mannose-binding, 1 (LMAN1), mRNA protein abundance compared with control group. |
Ligases (EC 6) |
Acetoacetyl-CoA synthetase (AACS) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
AACS protein abundance levels: decrease (FC = 0.76) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the decrease of AACS protein abundance compared with control group. |
cDNA FLJ54220 |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
cDNA FLJ54220, highly similar to Long-chain-fatty-acid--CoA ligase 1 protein abundance levels: increase (FC = 5.98) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of cDNA FLJ54220, highly similar to Long-chain-fatty-acid--CoA ligase 1 protein abundance compared with control group. |
cDNA FLJ95587 |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
cDNA, FLJ95587, highly similar to Homo sapiens ureidopropionase, beta (FC = 12.00) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of cDNA, FLJ95587, highly similar to Homo sapiens ureidopropionase, beta (UPB1), mRNA protein abundance compared with control group. |
Long-chain-fatty-acid-CoA ligase 1 (ACSL1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (2 hours) |
Induced Change |
ACSL1 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of ACSL1 protein expression compared with control group. |
Long-chain-fatty-acid-CoA ligase 5 (ACSL5) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[4] |
Introduced Variation |
Glutamine addition (576 hours) |
Induced Change |
ACSL5 protein expression levels: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that glutamine addition causes the decrease of ACSL5 protein expression compared with control group. |
Succinyl-CoA synthetase alpha (SUCLG1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
SUCLG1 protein abundance levels: increase (FC = 1.56) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of SUCLG1 protein abundance compared with control group. |
Succinyl-CoA synthetase beta-G chain (SUCLG2) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
SUCLG2 protein abundance levels: increase (FC = 1.34) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of SUCLG2 protein abundance compared with control group. |
Tyrosyl-tRNA synthetase (YARS2) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
YARS2 protein abundance levels: increase (FC = 1.52) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of YARS2 protein abundance compared with control group. |
Lipid binding protein (LBP) |
cDNA FLJ38349 |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
cDNA FLJ38349 fis, clone FEBRA1000057, highly similar to PCTP-like protein protein abundance levels: increase (FC = 4.23) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of cDNA FLJ38349 fis, clone FEBRA1000057, highly similar to PCTP-like protein protein abundance compared with control group. |
Lipocalin (LipC) |
Plasma retinol-binding protein (RBP4) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[4] |
Introduced Variation |
Glutamine addition (576 hours) |
Induced Change |
RBP4 protein expression levels: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that glutamine addition causes the decrease of RBP4 protein expression compared with control group. |
Lyases (EC 4) |
Alpha-enolase (ENO1) |
Click to Show/Hide the Full List of Regulating Pair(s): 2 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair (1) |
Experim Info
click to show the details of experiment for validating this pair
|
[8] |
Introduced Variation |
Glutamine addition (5 hours) |
Induced Change |
ENO1 protein expression levels: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Inflammatory bowel disease [ICD-11: DD72]
|
Details |
It is reported that glutamine addition causes the decrease of ENO1 protein expression compared with control group. |
Regulating Pair (2) |
Experim Info
click to show the details of experiment for validating this pair
|
[7] |
Introduced Variation |
Glutamine decrease (48 hours) |
Induced Change |
ENO1 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine decrease causes the increase of ENO1 protein expression compared with control group. |
Delta-aminolevulinic acid dehydratase (ALAD) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
ALAD protein abundance levels: increase (FC = 2.56) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of ALAD protein abundance compared with control group. |
Fructose-bisphosphate aldolase B (ALDOB) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
ALDOB protein abundance levels: increase (FC = 2.83) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of ALDOB protein abundance compared with control group. |
Histidine ammonia-lyase (HAL) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
HAL protein abundance levels: increase (FC = 3.00) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of HAL protein abundance compared with control group. |
Phosphoenolpyruvate carboxykinase 2 (PCK2) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[4] |
Introduced Variation |
Glutamine addition (576 hours) |
Induced Change |
PCK2 protein expression levels: decrease (FC = 1.6) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that glutamine addition causes the decrease of PCK2 protein expression compared with control group. |
Lysosome membrane glycoprotein (LAMP) |
cDNA FLJ58780 |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
cDNA FLJ58780, highly similar to Homo sapiens lysosomal-associated membrane protein 2 (FC = 1.60) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of cDNA FLJ58780, highly similar to Homo sapiens lysosomal-associated membrane protein 2 (LAMP2), transcript variant LAMP2B, mRNA protein abundance compared with control group. |
Major facilitator superfamily (MFS) |
cDNA FLJ95288 |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
cDNA, FLJ95288, highly similar to Homo sapiens feline leukemia virus subgroup C cellular receptor (FC = 1.52) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of cDNA, FLJ95288, highly similar to Homo sapiens feline leukemia virus subgroup C cellular receptor (FLVCR), mRNA protein abundance compared with control group. |
Melanoma-associated antigen (MAA) |
cDNA FLJ93871 |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
cDNA, FLJ93871, highly similar to Homo sapiens melanoma antigen, family B, 2 (FC = 0.72) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the decrease of cDNA, FLJ93871, highly similar to Homo sapiens melanoma antigen, family B, 2 (MAGEB2), mRNA protein abundance compared with control group. |
Melanoma-associated antigen 6 (MAGEA6) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
MAGEA6 protein abundance levels: decrease (FC = 0.66) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the decrease of MAGEA6 protein abundance compared with control group. |
Mitochondrial carrier (MC) |
Mitochondrial carrier homolog 2 (MTCH2) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
MTCH2 protein abundance levels: increase (FC = 1.50) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of MTCH2 protein abundance compared with control group. |
Mitosis protein (MP) |
Thioredoxin-like protein 4B (TXNL4B) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[2] |
Introduced Variation |
Glutamine addition (12 hours) |
Induced Change |
TXNL4B protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Inflammatory bowel disease [ICD-11: DD72]
|
Details |
It is reported that glutamine addition causes the increase of TXNL4B protein expression compared with control group. |
Myosin-kinesin (MK) |
Kinesin-like protein KIF2C (KIF2C) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
KIF2C protein abundance levels: decrease (FC = 0.75) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the decrease of KIF2C protein abundance compared with control group. |
Myristoylated ARCK substrate (MARCKS) |
Myristoylated alanine-rich C-kinase substrate (MARCKS) |
Click to Show/Hide the Full List of Regulating Pair(s): 2 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair (1) |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glutamine addition (24 hours) |
Induced Change |
MARCKS protein expression levels: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that glutamine addition causes the decrease of MARCKS protein expression compared with control group. |
Regulating Pair (2) |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
MARCKS protein abundance levels: increase (FC = 1.40) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of MARCKS protein abundance compared with control group. |
Nonaspanin (TM9SF) |
Transmembrane 9 superfamily member |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
transmembrane 9 superfamily member protein abundance levels: increase (FC = 1.36) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of transmembrane 9 superfamily member protein abundance compared with control group. |
Nuclear mRNA exporter (mRNA-E) |
RNA-binding protein with serine-rich 1 (RNPS1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
RNPS1 protein abundance levels: increase (FC = 1.42) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of RNPS1 protein abundance compared with control group. |
Nuclear transport factor (NTF) |
Nuclear transport factor 2 (NUF2) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
NUTF2 protein abundance levels: increase (FC = 1.67) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of NUTF2 protein abundance compared with control group. |
Occludin (OCC) |
Occludin (OCLN) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[6] |
Introduced Variation |
Glutamine decrease (504 hours) |
Induced Change |
OCLN protein expression levels: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that glutamine decrease causes the decrease of OCLN protein expression compared with control group. |
OCIA domain-containing protein (OCIAD) |
OCIA domain-containing protein 1 (OCIAD1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
OCIAD1 protein abundance levels: increase (FC = 1.36) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of OCIAD1 protein abundance compared with control group. |
Organellar-targeting adaptor protein (O-APC) |
Beta-4-adaptin (AP4B1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
AP4B1 protein abundance levels: decrease (FC = 0.72) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the decrease of AP4B1 protein abundance compared with control group. |
Sigma-adaptin 1A (AP1S1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[2] |
Introduced Variation |
Glutamine addition (12 hours) |
Induced Change |
AP1S1 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Inflammatory bowel disease [ICD-11: DD72]
|
Details |
It is reported that glutamine addition causes the increase of AP1S1 protein expression compared with control group. |
Oxidoreductases (EC 1) |
Alcohol dehydrogenase 1C (ADH1C) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
ADH1C protein abundance levels: increase (FC = 11.02) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of ADH1C protein abundance compared with control group. |
Aldehyde dehydrogenase (ALDH2) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (2 hours) |
Induced Change |
ALDH2 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of ALDH2 protein expression compared with control group. |
Aldehyde dehydrogenase 12 (ALDH12) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
ALDH8A1 protein abundance levels: increase (FC = 10.20) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of ALDH8A1 protein abundance compared with control group. |
Aldehyde dehydrogenase 4A1 (ALDH4A1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
ALDH4A1 protein abundance levels: increase (FC = 5.52) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of ALDH4A1 protein abundance compared with control group. |
Aldehyde dehydrogenase 6A1 (ALDH6A1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
ALDH6A1 protein abundance levels: increase (FC = 3.56) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of ALDH6A1 protein abundance compared with control group. |
Aminoadipate-saldehyde synthase (AASS) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
AASS protein abundance levels: increase (FC = 2.81) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of AASS protein abundance compared with control group. |
cDNA FLJ33079 |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
cDNA FLJ33079 fis, clone TRACH2000306, highly similar to Dimethylglycine dehydrogenase, mitochondrial protein abundance levels: increase (FC = 5.21) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of cDNA FLJ33079 fis, clone TRACH2000306, highly similar to Dimethylglycine dehydrogenase, mitochondrial protein abundance compared with control group. |
cDNA FLJ51786 |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
cDNA FLJ51786, highly similar to Retinal dehydrogenase 1 protein abundance levels: increase (FC = 12.47) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of cDNA FLJ51786, highly similar to Retinal dehydrogenase 1 protein abundance compared with control group. |
Cytochrome P450 2A13 (CYP2A13) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
CYP2A13 protein abundance levels: increase (FC = 2.98) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of CYP2A13 protein abundance compared with control group. |
Cytosolic malate dehydrogenase (MDH1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[7] |
Introduced Variation |
Glutamine decrease (48 hours) |
Induced Change |
MDH1 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine decrease causes the increase of MDH1 protein expression compared with control group. |
D-beta-hydroxybutyrate dehydrogenase (BDH1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
BDH1 protein abundance levels: increase (FC = 4.16) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of BDH1 protein abundance compared with control group. |
Debrisoquine 4-hydroxylase (CYP2D6) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
CYP2D6 protein abundance levels: increase (FC = 8.32) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of CYP2D6 protein abundance compared with control group. |
Delta(24)-sterol reductase (NBLA03646) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
NBLA03646 protein abundance levels: decrease (FC = 0.65) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the decrease of NBLA03646 protein abundance compared with control group. |
Dermal papilla derived protein 12 (DERP12) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
DERP12 protein abundance levels: decrease (FC = 0.75) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the decrease of DERP12 protein abundance compared with control group. |
Dihydropteridine reductase (QDPR) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
QDPR protein abundance levels: increase (FC = 2.29) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of QDPR protein abundance compared with control group. |
Electron-transferring-flavoprotein dehydrogenase (ETFDH) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
ETFDH protein abundance levels: increase (FC = 1.68) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of ETFDH protein abundance compared with control group. |
Ferritin (FTH1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
FTH1 protein abundance levels: increase (FC = 1.35) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of FTH1 protein abundance compared with control group. |
Flavin dimethylaniline monoxygenase 3 (FMO3) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
FMO3 protein abundance levels: increase (FC = 2.17) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of FMO3 protein abundance compared with control group. |
Formyltetrahydrofolate dehydrogenase (ALDH1L2) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
ALDH1L2 protein abundance levels: increase (FC = 1.82) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of ALDH1L2 protein abundance compared with control group. |
Glyceraldehyde-3-phosphate dehydrogenase 1 (GAPDH) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[7] |
Introduced Variation |
Glutamine decrease (48 hours) |
Induced Change |
GAPDH protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine decrease causes the increase of GAPDH protein expression compared with control group. |
GMP reductase 2 (GMPR2) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
GMPR2 protein abundance levels: decrease (FC = 0.72) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the decrease of GMPR2 protein abundance compared with control group. |
Heme oxygenase 1 (HMOX1) |
Click to Show/Hide the Full List of Regulating Pair(s): 2 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair (1) |
Experim Info
click to show the details of experiment for validating this pair
|
[11] |
Introduced Variation |
Glutamine addition (6 hours) |
Induced Change |
HMOX1 mRNA levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Inflammatory bowel disease [ICD-11: DD72]
|
Details |
It is reported that glutamine addition causes the increase of HMOX1 mRNA levels compared with control group. |
Regulating Pair (2) |
Experim Info
click to show the details of experiment for validating this pair
|
[11] |
Introduced Variation |
Glutamine addition (6 hours) |
Induced Change |
HMOX1 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Inflammatory bowel disease [ICD-11: DD72]
|
Details |
It is reported that glutamine addition causes the increase of HMOX1 protein expression compared with control group. |
Hydroxyisobutyrate dehydrogenase (HIBADH) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
HIBADH protein abundance levels: increase (FC = 1.49) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of HIBADH protein abundance compared with control group. |
Hydroxyphenylpyruvic acid oxidase (HPPDase) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
HPD protein abundance levels: increase (FC = 3.14) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of HPD protein abundance compared with control group. |
Isocitrate dehydrogenase NAD 3 alpha (IDH3A) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glutamine addition (24 hours) |
Induced Change |
IDH3A protein expression levels: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that glutamine addition causes the decrease of IDH3A protein expression compared with control group. |
Isovaleryl-CoA dehydrogenase (IVD) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
IVD protein abundance levels: increase (FC = 2.05) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of IVD protein abundance compared with control group. |
Lactate dehydrogenase A (LDHA) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[7] |
Introduced Variation |
Glutamine decrease (48 hours) |
Induced Change |
LDHA protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine decrease causes the increase of LDHA protein expression compared with control group. |
Medium-chain specific acyl-CoA dehydrogenase (ACADM) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[4] |
Introduced Variation |
Glutamine addition (576 hours) |
Induced Change |
ACADM protein expression levels: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that glutamine addition causes the decrease of ACADM protein expression compared with control group. |
Methanethiol oxidase (MTO) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
SELENBP1 protein abundance levels: increase (FC = 2.61) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of SELENBP1 protein abundance compared with control group. |
NADP-dependent malic enzyme (ME1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[7] |
Introduced Variation |
Glutamine decrease (48 hours) |
Induced Change |
ME1 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine decrease causes the increase of ME1 protein expression compared with control group. |
Nitric-oxide synthase endothelial (NOS3) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[9] |
Introduced Variation |
Glutamine addition (6 hours) |
Induced Change |
NOS3 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Sepsis [ICD-11: 1G40]
|
Details |
It is reported that glutamine addition causes the increase of NOS3 protein expression compared with control group. |
Nitric-oxide synthase inducible (NOS2) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[9] |
Introduced Variation |
Glutamine addition (6 hours) |
Induced Change |
NOS2 protein expression levels: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Sepsis [ICD-11: 1G40]
|
Details |
It is reported that glutamine addition causes the decrease of NOS2 protein expression compared with control group. |
Peroxisomal acyl-coenzyme A oxidase 1 (ACOX1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (2 hours) |
Induced Change |
ACOX1 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of ACOX1 protein expression compared with control group. |
Phosphoglycerate dehydrogenase (PHGDH) |
Click to Show/Hide the Full List of Regulating Pair(s): 2 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair (1) |
Experim Info
click to show the details of experiment for validating this pair
|
[7] |
Introduced Variation |
Glutamine decrease (48 hours) |
Induced Change |
PHGDH protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cervical Cancer [ICD-11: 2C77]
... |
Details |
It is reported that glutamine decrease causes the increase of PHGDH protein expression compared with control group. |
Regulating Pair (2) |
Experim Info
click to show the details of experiment for validating this pair
|
[7] |
Introduced Variation |
Glutamine decrease (48 hours) |
Induced Change |
PHGDH mRNA levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cervical Cancer [ICD-11: 2C77]
... |
Details |
It is reported that glutamine decrease causes the increase of PHGDH mRNA levels compared with control group. |
Retinal dehydrogenase 1 (RALDH1) |
Click to Show/Hide the Full List of Regulating Pair(s): 2 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair (1) |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (2 hours) |
Induced Change |
ALDH1A1 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of ALDH1A1 protein expression compared with control group. |
Regulating Pair (2) |
Experim Info
click to show the details of experiment for validating this pair
|
[8] |
Introduced Variation |
Glutamine addition (5 hours) |
Induced Change |
ALDH1A1 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Inflammatory bowel disease [ICD-11: DD72]
|
Details |
It is reported that glutamine addition causes the increase of ALDH1A1 protein expression compared with control group. |
S-nitrosoglutathione reductase (CBR1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
CBR1 protein abundance levels: increase (FC = 1.31) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of CBR1 protein abundance compared with control group. |
Short chain dehydrogenase/reductase 17C1 (DECR2) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
DECR2 protein abundance levels: increase (FC = 1.36) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of DECR2 protein abundance compared with control group. |
Short chain dehydrogenase/reductase 18C1 (DECR1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
DECR1 protein abundance levels: increase (FC = 2.26) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of DECR1 protein abundance compared with control group. |
Short-chain acyl-CoA dehydrogenase (ACADS) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
ACADS protein abundance levels: increase (FC = 3.29) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of ACADS protein abundance compared with control group. |
Superoxide dismutase Mn (SOD Mn) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[8] |
Introduced Variation |
Glutamine addition (5 hours) |
Induced Change |
SOD2 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Inflammatory bowel disease [ICD-11: DD72]
|
Details |
It is reported that glutamine addition causes the increase of SOD2 protein expression compared with control group. |
Xanthine dehydrogenase/oxidase (XDH) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
XDH protein abundance levels: increase (FC = 2.93) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of XDH protein abundance compared with control group. |
Phosducin (Pho) |
cDNA FLJ51322 |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
cDNA FLJ51322, highly similar to Phosducin-like protein 3 protein abundance levels: increase (FC = 1.46) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of cDNA FLJ51322, highly similar to Phosducin-like protein 3 protein abundance compared with control group. |
Pleiotrophin (Plei) |
APOBEC1-binding protein 2 (ABBP-2) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
DNAJB11 protein abundance levels: increase (FC = 1.31) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of DNAJB11 protein abundance compared with control group. |
Pore-forming globin (PFG) |
Hemoglobin alpha (HBA) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
HBA1 MORE protein abundance levels: increase (FC = 2.88) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of HBA1 MORE protein abundance compared with control group. |
Hemoglobin beta (HBB) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
HBB protein abundance levels: increase (FC = 4.89) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of HBB protein abundance compared with control group. |
Prefoldin (Pref) |
p53 and DNA damage-regulated protein 1 (PDRG1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[2] |
Introduced Variation |
Glutamine addition (12 hours) |
Induced Change |
PDRG1 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Inflammatory bowel disease [ICD-11: DD72]
|
Details |
It is reported that glutamine addition causes the increase of PDRG1 protein expression compared with control group. |
Profilin (Prof) |
Profilin-2 (PFN2) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
PFN2 protein abundance levels: decrease (FC = 0.74) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the decrease of PFN2 protein abundance compared with control group. |
Resistance-nodulation-cell division (RND) |
NPC intracellular cholesterol transporter 2 (NPC2) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
NPC2 protein abundance levels: increase (FC = 1.37) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of NPC2 protein abundance compared with control group. |
Ribonucleoprotein (RPT) |
Small nuclear ribonucleoprotein E (SNRPE) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
SNRPE protein abundance levels: decrease (FC = 0.55) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the decrease of SNRPE protein abundance compared with control group. |
Ribosomal protein (Ribo) |
Laminin receptor 37/67kDa (LRP/LR) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[8] |
Introduced Variation |
Glutamine addition (5 hours) |
Induced Change |
RPSA protein expression levels: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Inflammatory bowel disease [ICD-11: DD72]
|
Details |
It is reported that glutamine addition causes the decrease of RPSA protein expression compared with control group. |
Ribosomal protein L15 (RPL15) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
RPL15 protein abundance levels: decrease (FC = 0.76) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the decrease of RPL15 protein abundance compared with control group. |
Ribosomal protein L17 (MRPL17) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
MRPL17 protein abundance levels: decrease (FC = 0.77) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the decrease of MRPL17 protein abundance compared with control group. |
Ribosomal protein L27 (RPL27) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
RPL27 protein abundance levels: decrease (FC = 0.75) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the decrease of RPL27 protein abundance compared with control group. |
Ribosomal protein L3 (MRPL3) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
MRPL3 protein abundance levels: decrease (FC = 0.72) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the decrease of MRPL3 protein abundance compared with control group. |
Ribosomal protein L35a (RPL35A) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
RPL35A protein abundance levels: decrease (FC = 0.73) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the decrease of RPL35A protein abundance compared with control group. |
Ribosomal protein L47 (MRPL47) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
MRPL47 protein abundance levels: decrease (FC = 0.67) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the decrease of MRPL47 protein abundance compared with control group. |
Ribosomal protein lateral stalk P2 (RPLP2) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[2] |
Introduced Variation |
Glutamine addition (16 hours) |
Induced Change |
RPLP2 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Inflammatory bowel disease [ICD-11: DD72]
|
Details |
It is reported that glutamine addition causes the increase of RPLP2 protein expression compared with control group. |
Ribosomal protein S12 (RPS12) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[2] |
Introduced Variation |
Glutamine addition (12 hours) |
Induced Change |
RPS12 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Inflammatory bowel disease [ICD-11: DD72]
|
Details |
It is reported that glutamine addition causes the increase of RPS12 protein expression compared with control group. |
Ribosomal protein S18 (RPS18) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
RPS18 protein abundance levels: decrease (FC = 0.76) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the decrease of RPS18 protein abundance compared with control group. |
Ribosomal protein S21 (RPS21) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
RPS21 protein abundance levels: decrease (FC = 0.73) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the decrease of RPS21 protein abundance compared with control group. |
Ribosomal protein S25 (MRPS25) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
MRPS25 protein abundance levels: decrease (FC = 0.72) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the decrease of MRPS25 protein abundance compared with control group. |
Ribosomal protein S5 (RPS5) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
RPS5 protein abundance levels: increase (FC = 1.34) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of RPS5 protein abundance compared with control group. |
Ribosomal protein S6 (RPS6) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[12] |
Introduced Variation |
Glutamine decrease (1 hours) |
Induced Change |
RPS6 protein phosphorylation levels: increase (FC = 4) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cervical Cancer [ICD-11: 2C77]
|
Details |
It is reported that glutamine decrease causes the increase of RPS6 protein phosphorylation compared with control group. |
RNA recognition motif (Rnrmo) |
cDNA FLJ58832 |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
cDNA FLJ58832, highly similar to Heterogeneous nuclear ribonucleoprotein A3 protein abundance levels: increase (FC = 1.70) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of cDNA FLJ58832, highly similar to Heterogeneous nuclear ribonucleoprotein A3 protein abundance compared with control group. |
cDNA FLJ76387 |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
cDNA FLJ76387, highly similar to Homo sapiens splicing factor, arginine/serine-rich 9 (FC = 0.34) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the decrease of cDNA FLJ76387, highly similar to Homo sapiens splicing factor, arginine/serine-rich 9 (SFRS9), mRNA protein abundance compared with control group. |
G-rich sequence factor 1 (GRSF1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[2] |
Introduced Variation |
Glutamine addition (12 hours) |
Induced Change |
GRSF1 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Inflammatory bowel disease [ICD-11: DD72]
|
Details |
It is reported that glutamine addition causes the increase of GRSF1 protein expression compared with control group. |
Polyadenylate-binding nuclear protein 1 (PABPN1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
PABPN1 protein abundance levels: increase (FC = 1.45) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of PABPN1 protein abundance compared with control group. |
RNA-binding protein EWS (EWSR1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
EWSR1 protein abundance levels: increase (FC = 1.32) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of EWSR1 protein abundance compared with control group. |
U1 small nuclear ribonucleoprotein A (SNRPA) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
SNRPA protein abundance levels: increase (FC = 1.39) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of SNRPA protein abundance compared with control group. |
RNA-binding protein (RBP) |
cDNA FLJ56221 |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
cDNA FLJ56221, highly similar to YTH domain protein 3 protein abundance levels: increase (FC = 1.33) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of cDNA FLJ56221, highly similar to YTH domain protein 3 protein abundance compared with control group. |
Fragile X mental retardation protein 1 (FMR1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
FMR1 protein abundance levels: increase (FC = 1.32) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of FMR1 protein abundance compared with control group. |
Nuclear ribonucleoprotein K (HNRNPK) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[4] |
Introduced Variation |
Glutamine addition (576 hours) |
Induced Change |
HNRNPK protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that glutamine addition causes the increase of HNRNPK protein expression compared with control group. |
Regulator of nonsense transcripts 2 (UPF2) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
UPF2 protein abundance levels: decrease (FC = 0.71) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the decrease of UPF2 protein abundance compared with control group. |
S100 calcium-binding protein (S100) |
Aging-associated gene 13 (AAG13) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
S100A16 protein abundance levels: increase (FC = 1.39) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of S100A16 protein abundance compared with control group. |
Selenoprotein M/F (SelM/F) |
Selenoprotein M (SELM) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[2] |
Introduced Variation |
Glutamine addition (12 hours) |
Induced Change |
SELENOM protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Inflammatory bowel disease [ICD-11: DD72]
|
Details |
It is reported that glutamine addition causes the increase of SELENOM protein expression compared with control group. |
Serine/arginine-related protein (SAR) |
cDNA FLJ58941 |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
cDNA FLJ58941, moderately similar to Arginine/serine-rich coiled coil protein 1 protein abundance levels: decrease (FC = 0.72) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the decrease of cDNA FLJ58941, moderately similar to Arginine/serine-rich coiled coil protein 1 protein abundance compared with control group. |
Serum albumin (ALB) |
Rpp25-like protein (RPP25L) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
RPP25L protein abundance levels: decrease (FC = 0.65) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the decrease of RPP25L protein abundance compared with control group. |
Small ubiquitin-related modifier (SURM) |
Small ubiquitin-related modifier 1 (SUMO1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[2] |
Introduced Variation |
Glutamine addition (12 hours) |
Induced Change |
SUMO1 protein expression levels: increase (FC = 2.506) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Inflammatory bowel disease [ICD-11: DD72]
|
Details |
It is reported that glutamine addition causes the increase of SUMO1 protein expression compared with control group. |
Small ubiquitin-related modifier 3 (SUMO3) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[2] |
Introduced Variation |
Glutamine addition (12 hours) |
Induced Change |
SUMO3 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Inflammatory bowel disease [ICD-11: DD72]
|
Details |
It is reported that glutamine addition causes the increase of SUMO3 protein expression compared with control group. |
Sorting nexin (SN) |
Sorting nexin-12 (SNX12) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[2] |
Introduced Variation |
Glutamine addition (12 hours) |
Induced Change |
SNX12 protein expression levels: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Inflammatory bowel disease [ICD-11: DD72]
|
Details |
It is reported that glutamine addition causes the decrease of SNX12 protein expression compared with control group. |
Stathmin (StaM) |
Stathmin (STMN1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glutamine addition (24 hours) |
Induced Change |
STMN1 protein expression levels: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that glutamine addition causes the decrease of STMN1 protein expression compared with control group. |
Syntaxin binding protein (STXBP) |
Sec1 family domain-containing protein 1 (SCFD1) |
Click to Show/Hide the Full List of Regulating Pair(s): 2 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair (1) |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glutamine addition (24 hours) |
Induced Change |
SCFD1 protein expression levels: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that glutamine addition causes the decrease of SCFD1 protein expression compared with control group. |
Regulating Pair (2) |
Experim Info
click to show the details of experiment for validating this pair
|
[2] |
Introduced Variation |
Glutamine addition (12 hours) |
Induced Change |
SCFD1 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Inflammatory bowel disease [ICD-11: DD72]
|
Details |
It is reported that glutamine addition causes the increase of SCFD1 protein expression compared with control group. |
Thioredoxin (ThReDo) |
Thioredoxin-like protein 1 (TXNL1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[2] |
Introduced Variation |
Glutamine addition (12 hours) |
Induced Change |
TXNL1 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Inflammatory bowel disease [ICD-11: DD72]
|
Details |
It is reported that glutamine addition causes the increase of TXNL1 protein expression compared with control group. |
Thyroid hormone receptor-associated (THRA) |
Thyroid hormone receptor-associated protein 3 (THRAP3) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
THRAP3 protein abundance levels: increase (FC = 1.61) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of THRAP3 protein abundance compared with control group. |
TP53RK-binding protein (TPRKB) |
cDNA FLJ76394 |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
cDNA FLJ76394, highly similar to Homo sapiens CGI-121 protein (FC = 0.69) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the decrease of cDNA FLJ76394, highly similar to Homo sapiens CGI-121 protein (CGI-121), mRNA protein abundance compared with control group. |
Transcription factor (TF) |
Dimethylaniline monooxygenase 6 (FMO6P) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
FMO6 protein abundance levels: increase (FC = 2.17) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of FMO6 protein abundance compared with control group. |
Flavin dimethylaniline monoxygenase 1 (FMO1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
FMO1 protein abundance levels: increase (FC = 2.17) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of FMO1 protein abundance compared with control group. |
Flavin dimethylaniline monoxygenase 2 (FMO2) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
FMO2 protein abundance levels: increase (FC = 2.17) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of FMO2 protein abundance compared with control group. |
Flavin dimethylaniline monoxygenase 4 (FMO4) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
FMO4 protein abundance levels: increase (FC = 2.17) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of FMO4 protein abundance compared with control group. |
Flavin-containing monooxygenase 5 (FMO5) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
FMO5 protein abundance levels: increase (FC = 2.17) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of FMO5 protein abundance compared with control group. |
Transcription factor BTF3 homolog 4 (BTF3L4) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
BTF3L4 protein abundance levels: increase (FC = 1.52) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of BTF3L4 protein abundance compared with control group. |
Transcription regulator (TR) |
BRG1-associated factor 170 (BAF170) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
SMARCC2 protein abundance levels: increase (FC = 1.32) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of SMARCC2 protein abundance compared with control group. |
Transferases (EC 2) |
Acetyl-CoA C-myristoyltransferase (ACAA1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
acetyl-CoA C-myristoyltransferase protein abundance levels: increase (FC = 1.35) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of acetyl-CoA C-myristoyltransferase protein abundance compared with control group. |
Adenosine kinase (ADK) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
ADK protein abundance levels: increase (FC = 1.71) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of ADK protein abundance compared with control group. |
Adenylate kinase 6 (AK6) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
AK6 protein abundance levels: decrease (FC = 0.67) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the decrease of AK6 protein abundance compared with control group. |
Alanine-glyoxylate transferase 2 (AGXT2) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
AGXT2 protein abundance levels: increase (FC = 5.17) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of AGXT2 protein abundance compared with control group. |
Aurora kinase (ARK1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
aurora kinase protein abundance levels: decrease (FC = 0.76) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the decrease of aurora kinase protein abundance compared with control group. |
cDNA FLJ53115 |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
cDNA FLJ53115, highly similar to Propionyl-CoA carboxylase beta chain, mitochondrial protein abundance levels: increase (FC = 5.32) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of cDNA FLJ53115, highly similar to Propionyl-CoA carboxylase beta chain, mitochondrial protein abundance compared with control group. |
cDNA FLJ55549 |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
cDNA FLJ55549, highly similar to 3-ketoacyl-CoA thiolase, peroxisomal protein abundance levels: increase (FC = 1.98) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of cDNA FLJ55549, highly similar to 3-ketoacyl-CoA thiolase, peroxisomal protein abundance compared with control group. |
cDNA FLJ77874 |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
cDNA FLJ77874, highly similar to Homo sapiens glycine C-acetyltransferase (FC = 9.45) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of cDNA FLJ77874, highly similar to Homo sapiens glycine C-acetyltransferase (2-amino-3-ketobutyrate coenzyme A ligase), mRNA protein abundance compared with control group. |
cDNA FLJ96222 |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
cDNA, FLJ96222, highly similar to Homo sapiens betaine-homocysteine methyltransferase (FC = 5.78) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of cDNA, FLJ96222, highly similar to Homo sapiens betaine-homocysteine methyltransferase (BHMT), mRNA protein abundance compared with control group. |
Chitobiosyldiphosphodolichol beta-mannosyltransferase (ALG1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
ALG1 protein abundance levels: decrease (FC = 0.73) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the decrease of ALG1 protein abundance compared with control group. |
Cytoplasmic aspartate aminotransferase (GOT1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[7] |
Introduced Variation |
Glutamine decrease (48 hours) |
Induced Change |
GOT1 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine decrease causes the increase of GOT1 protein expression compared with control group. |
Dehydrogenase-phosphopantetheinyl transferase (AASDHPPT) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
AASDHPPT protein abundance levels: decrease (FC = 0.75) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the decrease of AASDHPPT protein abundance compared with control group. |
E3 ubiquitin-protein ligase ARIH1 (ARIH1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[2] |
Introduced Variation |
Glutamine addition (12 hours) |
Induced Change |
ARIH1 protein expression levels: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Inflammatory bowel disease [ICD-11: DD72]
|
Details |
It is reported that glutamine addition causes the decrease of ARIH1 protein expression compared with control group. |
E3 ubiquitin-protein ligase RNF114 (RNF114) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
RNF114 protein abundance levels: increase (FC = 2.02) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of RNF114 protein abundance compared with control group. |
Ephrin type-A receptor 5 (EPHA5) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[2] |
Introduced Variation |
Glutamine addition (12 hours) |
Induced Change |
EPHA5 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Inflammatory bowel disease [ICD-11: DD72]
|
Details |
It is reported that glutamine addition causes the increase of EPHA5 protein expression compared with control group. |
Extracellular signal-regulated kinase 1 (ERK1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[9] |
Introduced Variation |
Glutamine addition (6 hours) |
Induced Change |
MAPK3 protein phosphorylation levels: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Sepsis [ICD-11: 1G40]
|
Details |
It is reported that glutamine addition causes the decrease of MAPK3 protein phosphorylation compared with control group. |
Extracellular signal-regulated kinase 2 (ERK2) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[9] |
Introduced Variation |
Glutamine addition (6 hours) |
Induced Change |
MAPK1 protein phosphorylation levels: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Sepsis [ICD-11: 1G40]
|
Details |
It is reported that glutamine addition causes the decrease of MAPK1 protein phosphorylation compared with control group. |
Glutathione S-transferase A3 (GSTA3) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
GSTA3 protein abundance levels: increase (FC = 3.89) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of GSTA3 protein abundance compared with control group. |
Glutathione S-transferase Mu 1 (GSTM1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glutamine addition (24 hours) |
Induced Change |
GSTM1 protein expression levels: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that glutamine addition causes the decrease of GSTM1 protein expression compared with control group. |
Glutathione S-transferase omega-2 (GSTO2) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[2] |
Introduced Variation |
Glutamine addition (12 hours) |
Induced Change |
GSTO2 protein expression levels: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Inflammatory bowel disease [ICD-11: DD72]
|
Details |
It is reported that glutamine addition causes the decrease of GSTO2 protein expression compared with control group. |
Glycerol kinase (GK) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
GK protein abundance levels: increase (FC = 1.85) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of GK protein abundance compared with control group. |
Glycogen-branching enzyme (GBE1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
GBE1 protein abundance levels: increase (FC = 1.34) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of GBE1 protein abundance compared with control group. |
HECT/RCC1-like-containing protein 1 (HERC1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
HERC1 protein abundance levels: decrease (FC = 0.71) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the decrease of HERC1 protein abundance compared with control group. |
Hexokinase-2 (HK2) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[7] |
Introduced Variation |
Glutamine decrease (48 hours) |
Induced Change |
HK2 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine decrease causes the increase of HK2 protein expression compared with control group. |
Hydroxymethylglutaryl-CoA synthase 2 (HMGCS2) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[4] |
Introduced Variation |
Glutamine addition (576 hours) |
Induced Change |
HMGCS2 protein expression levels: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that glutamine addition causes the decrease of HMGCS2 protein expression compared with control group. |
Hypoxanthine-guanine phosphoribosyltransferase (HPRT1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glutamine addition (24 hours) |
Induced Change |
HPRT1 protein expression levels: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that glutamine addition causes the decrease of HPRT1 protein expression compared with control group. |
Interleukin-1 receptor-associated kinase-like 2 (IRAK2) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glutamine addition (24 hours) |
Induced Change |
IRAK2 protein expression levels: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that glutamine addition causes the decrease of IRAK2 protein expression compared with control group. |
MAP kinase p38 (MAPK12) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[9] |
Introduced Variation |
Glutamine addition (6 hours) |
Induced Change |
MAPK12 protein phosphorylation levels: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Sepsis [ICD-11: 1G40]
|
Details |
It is reported that glutamine addition causes the decrease of MAPK12 protein phosphorylation compared with control group. |
Methyltransferase-like protein 7A (METTL7A) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
METTL7A protein abundance levels: increase (FC = 1.56) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of METTL7A protein abundance compared with control group. |
Mitogen-activated protein kinase 13 (MAPK13) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[9] |
Introduced Variation |
Glutamine addition (6 hours) |
Induced Change |
MAPK13 protein phosphorylation levels: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Sepsis [ICD-11: 1G40]
|
Details |
It is reported that glutamine addition causes the decrease of MAPK13 protein phosphorylation compared with control group. |
N6-L-threonylcarbamoyladenine synthase (GCP1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
OSGEPL1 protein abundance levels: decrease (FC = 0.53) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the decrease of OSGEPL1 protein abundance compared with control group. |
Nicotinate-nucleotide pyrophosphorylase (QPRT) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
QPRT protein abundance levels: increase (FC = 1.37) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of QPRT protein abundance compared with control group. |
Ornithine delta-aminotransferase (OAT) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[4] |
Introduced Variation |
Glutamine addition (576 hours) |
Induced Change |
OAT protein expression levels: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that glutamine addition causes the decrease of OAT protein expression compared with control group. |
Ornithine transcarbamylase (OTC) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
OTC protein abundance levels: increase (FC = 4.22) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of OTC protein abundance compared with control group. |
Phosphofructo-1-kinase isozyme B (PFK-B) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[7] |
Introduced Variation |
Glutamine decrease (48 hours) |
Induced Change |
PFKL protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine decrease causes the increase of PFKL protein expression compared with control group. |
Phosphoglycerate kinase 1 (PGK1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[7] |
Introduced Variation |
Glutamine decrease (48 hours) |
Induced Change |
PGK1 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine decrease causes the increase of PGK1 protein expression compared with control group. |
Phosphoinositide dependent protein kinase-1 (PDPK1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (2 hours) |
Induced Change |
PDPK1 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of PDPK1 protein expression compared with control group. |
Phosphoserine aminotransferase (PSAT1) |
Click to Show/Hide the Full List of Regulating Pair(s): 2 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair (1) |
Experim Info
click to show the details of experiment for validating this pair
|
[7] |
Introduced Variation |
Glutamine decrease (48 hours) |
Induced Change |
PSAT1 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cervical Cancer [ICD-11: 2C77]
... |
Details |
It is reported that glutamine decrease causes the increase of PSAT1 protein expression compared with control group. |
Regulating Pair (2) |
Experim Info
click to show the details of experiment for validating this pair
|
[7] |
Introduced Variation |
Glutamine decrease (48 hours) |
Induced Change |
PSAT1 mRNA levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cervical Cancer [ICD-11: 2C77]
... |
Details |
It is reported that glutamine decrease causes the increase of PSAT1 mRNA levels compared with control group. |
Probable C-mannosyltransferase DPY19L2 (DPY19L2) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
DPY19L2 protein abundance levels: decrease (FC = 0.76) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the decrease of DPY19L2 protein abundance compared with control group. |
Protein kinase X (PRKX) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glutamine addition (24 hours) |
Induced Change |
PRKX protein expression levels: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that glutamine addition causes the decrease of PRKX protein expression compared with control group. |
Pyruvate kinase 1 (PKLR) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[7] |
Introduced Variation |
Glutamine decrease (48 hours) |
Induced Change |
PKLR protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine decrease causes the increase of PKLR protein expression compared with control group. |
RAC-beta serine/threonine-protein kinase (AKT2) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
AKT2 protein abundance levels: decrease (FC = 0.73) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the decrease of AKT2 protein abundance compared with control group. |
Ribosomal protein S6 kinase beta-1 (S6K1) |
Click to Show/Hide the Full List of Regulating Pair(s): 2 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair (1) |
Experim Info
click to show the details of experiment for validating this pair
|
[12] |
Introduced Variation |
Glutamine addition (1 hours) |
Induced Change |
RPS6KB1 protein abundance levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Ovarian cancer [ICD-11: 2C73]
|
Details |
It is reported that glutamine addition causes the increase of RPS6KB1 protein abundance compared with control group. |
Regulating Pair (2) |
Experim Info
click to show the details of experiment for validating this pair
|
[13] |
Introduced Variation |
Glutamine addition (96 hours) |
Induced Change |
RPS6KB1 protein phosphorylation levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Healthy individual
|
Details |
It is reported that glutamine addition causes the increase of RPS6KB1 protein phosphorylation compared with control group. |
S-adenosylmethionine synthase type-2 (MAT2A) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
MAT2A protein abundance levels: increase (FC = 6.26) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of MAT2A protein abundance compared with control group. |
Serine hydroxymethyltransferase (SHMT2) |
Click to Show/Hide the Full List of Regulating Pair(s): 2 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair (1) |
Experim Info
click to show the details of experiment for validating this pair
|
[7] |
Introduced Variation |
Glutamine decrease (48 hours) |
Induced Change |
SHMT2 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cervical Cancer [ICD-11: 2C77]
... |
Details |
It is reported that glutamine decrease causes the increase of SHMT2 protein expression compared with control group. |
Regulating Pair (2) |
Experim Info
click to show the details of experiment for validating this pair
|
[7] |
Introduced Variation |
Glutamine decrease (48 hours) |
Induced Change |
SHMT2 mRNA levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cervical Cancer [ICD-11: 2C77]
... |
Details |
It is reported that glutamine decrease causes the increase of SHMT2 mRNA levels compared with control group. |
Serine methylase (SHMT1) |
Click to Show/Hide the Full List of Regulating Pair(s): 2 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair (1) |
Experim Info
click to show the details of experiment for validating this pair
|
[7] |
Introduced Variation |
Glutamine decrease (48 hours) |
Induced Change |
SHMT1 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cervical Cancer [ICD-11: 2C77]
... |
Details |
It is reported that glutamine decrease causes the increase of SHMT1 protein expression compared with control group. |
Regulating Pair (2) |
Experim Info
click to show the details of experiment for validating this pair
|
[7] |
Introduced Variation |
Glutamine decrease (48 hours) |
Induced Change |
SHMT1 mRNA levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Cervical Cancer [ICD-11: 2C77]
... |
Details |
It is reported that glutamine decrease causes the increase of SHMT1 mRNA levels compared with control group. |
Serine/threonine-protein kinase mTOR (mTOR) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[12] |
Introduced Variation |
Glutamine addition (1 hours) |
Induced Change |
MTOR protein activity levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Ovarian cancer [ICD-11: 2C73]
|
Details |
It is reported that glutamine addition causes the increase of MTOR protein activity compared with control group. |
Stress-activated protein kinase 2a (p38 alpha) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[9] |
Introduced Variation |
Glutamine addition (6 hours) |
Induced Change |
MAPK14 protein phosphorylation levels: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Sepsis [ICD-11: 1G40]
|
Details |
It is reported that glutamine addition causes the decrease of MAPK14 protein phosphorylation compared with control group. |
TGF-beta-activated kinase 1 (MAP3K7) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[3] |
Introduced Variation |
Glutamine addition (24 hours) |
Induced Change |
MAP3K7 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Colon cancer [ICD-11: 2B90]
|
Details |
It is reported that glutamine addition causes the increase of MAP3K7 protein expression compared with control group. |
Transketolase-like protein 1 (TKTL1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[2] |
Introduced Variation |
Glutamine addition (12 hours) |
Induced Change |
TKTL1 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Inflammatory bowel disease [ICD-11: DD72]
|
Details |
It is reported that glutamine addition causes the increase of TKTL1 protein expression compared with control group. |
Ubiquitin-conjugating enzyme E2 C (UBE2C) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[2] |
Introduced Variation |
Glutamine addition (12 hours) |
Induced Change |
UBE2C protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Inflammatory bowel disease [ICD-11: DD72]
|
Details |
It is reported that glutamine addition causes the increase of UBE2C protein expression compared with control group. |
Ubiquitin-conjugating enzyme E2 G1 (UBE2G1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
UBE2G1 protein abundance levels: increase (FC = 1.40) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of UBE2G1 protein abundance compared with control group. |
Ubiquitin-conjugating enzyme E2 L3 (UBE2L3) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
UBE2L3 protein abundance levels: increase (FC = 1.35) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of UBE2L3 protein abundance compared with control group. |
Ubiquitin-conjugating enzyme E2 variant 2 (UBE2V2) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[2] |
Introduced Variation |
Glutamine addition (12 hours) |
Induced Change |
UBE2V2 protein expression levels: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Inflammatory bowel disease [ICD-11: DD72]
|
Details |
It is reported that glutamine addition causes the decrease of UBE2V2 protein expression compared with control group. |
Ubiquitin-protein ligase E2 (UBE2E2) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[2] |
Introduced Variation |
Glutamine addition (12 hours) |
Induced Change |
UBE2E2 protein expression levels: increase (FC = 3.418) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Inflammatory bowel disease [ICD-11: DD72]
|
Details |
It is reported that glutamine addition causes the increase of UBE2E2 protein expression compared with control group. |
Translation elongation factor (TEF) |
Elongation factor 1-alpha 3 (EEF1AL3) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
EEF1A1P5 protein abundance levels: increase (FC = 1.64) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of EEF1A1P5 protein abundance compared with control group. |
Translation initiation factor (TIF) |
eIF4E-binding protein 1 (EIF4EBP1) |
Click to Show/Hide the Full List of Regulating Pair(s): 2 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair (1) |
Experim Info
click to show the details of experiment for validating this pair
|
[14] |
Introduced Variation |
Glutamine decrease (6 hours) |
Induced Change |
EIF4EBP1 protein phosphorylation levels: decrease (FC = p-4E-BP1) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Inflammatory bowel disease [ICD-11: DD72]
|
Details |
It is reported that glutamine decrease causes the decrease of EIF4EBP1 protein phosphorylation compared with control group. |
Regulating Pair (2) |
Experim Info
click to show the details of experiment for validating this pair
|
[13] |
Introduced Variation |
Glutamine addition (96 hours) |
Induced Change |
EIF4EBP1 protein phosphorylation levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Healthy individual
|
Details |
It is reported that glutamine addition causes the increase of EIF4EBP1 protein phosphorylation compared with control group. |
PRO0189 |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
PRO0189 protein abundance levels: decrease (FC = 0.65) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the decrease of PRO0189 protein abundance compared with control group. |
Translocases (EC 7) |
Proteasome 26S ATPase 2 (PSMC2) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[2] |
Introduced Variation |
Glutamine addition (12 hours) |
Induced Change |
PSMC2 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Inflammatory bowel disease [ICD-11: DD72]
|
Details |
It is reported that glutamine addition causes the increase of PSMC2 protein expression compared with control group. |
Translocon-associated protein (TRAP) |
Translocon-associated protein delta (TRAPD) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[2] |
Introduced Variation |
Glutamine addition (12 hours) |
Induced Change |
SSR4 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Inflammatory bowel disease [ICD-11: DD72]
|
Details |
It is reported that glutamine addition causes the increase of SSR4 protein expression compared with control group. |
Transmembrane Emp24 domain-containing protein (TMED) |
Transmembrane emp24 domain-containing 7 (TMED7) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
TMED7 protein abundance levels: increase (FC = 1.54) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of TMED7 protein abundance compared with control group. |
Transmembrane protein (TMEM) |
HBeAg-binding protein 2 binding protein A (HBEBP2BPA) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
HBEBP2BPA protein abundance levels: increase (FC = 1.51) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of HBEBP2BPA protein abundance compared with control group. |
Tubulin-related (Tub) |
Tubulin-specific chaperone A (TBCA) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[2] |
Introduced Variation |
Glutamine addition (12 hours) |
Induced Change |
TBCA protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Inflammatory bowel disease [ICD-11: DD72]
|
Details |
It is reported that glutamine addition causes the increase of TBCA protein expression compared with control group. |
Tumour necrosis factor (TNF) |
Tumor necrosis factor (TNF) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[9] |
Introduced Variation |
Glutamine addition (6 hours) |
Induced Change |
TNF protein expression levels: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Sepsis [ICD-11: 1G40]
|
Details |
It is reported that glutamine addition causes the decrease of TNF protein expression compared with control group. |
Ubiquitin/ubiquinone (UbiQ) |
NADH:ubiquinone oxidoreductase B11 (NDUFB11) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[2] |
Introduced Variation |
Glutamine addition (12 hours) |
Induced Change |
NDUFB11 protein expression levels: increase |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Inflammatory bowel disease [ICD-11: DD72]
|
Details |
It is reported that glutamine addition causes the increase of NDUFB11 protein expression compared with control group. |
Ubiquitin D (UBD) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[2] |
Introduced Variation |
Glutamine addition (12 hours) |
Induced Change |
UBD protein expression levels: decrease |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Inflammatory bowel disease [ICD-11: DD72]
|
Details |
It is reported that glutamine addition causes the decrease of UBD protein expression compared with control group. |
Ubiquitin-like protein Nedd8 (NEDD8) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
NEDD8 protein abundance levels: increase (FC = 1.37) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of NEDD8 protein abundance compared with control group. |
Von willebrand factor (VWF) |
cDNA FLJ60769 |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
cDNA FLJ60769, highly similar to Inter-alpha-trypsin inhibitor heavy chain H3 protein abundance levels: increase (FC = 1.34) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of cDNA FLJ60769, highly similar to Inter-alpha-trypsin inhibitor heavy chain H3 protein abundance compared with control group. |
WD repeat protein (WRP) |
Guanine nucleotide-binding protein beta-4 (GNB4) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
GNB4 protein abundance levels: increase (FC = 1.57) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of GNB4 protein abundance compared with control group. |
WD repeat and SOCS box-containing protein 1 (WSB1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
WSB1 protein abundance levels: decrease (FC = 0.56) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the decrease of WSB1 protein abundance compared with control group. |
Zinc finger protein (ZIN) |
Delta transcription factor (NF-E1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
YY1 protein abundance levels: increase (FC = 1.42) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of YY1 protein abundance compared with control group. |
FLYWCH family member 2 (FLYWCH2) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
FLYWCH2 protein abundance levels: decrease (FC = 0.74) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the decrease of FLYWCH2 protein abundance compared with control group. |
Nuclear-interacting partner of ALK (ZC3HC1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
ZC3HC1 protein abundance levels: decrease (FC = 0.75) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the decrease of ZC3HC1 protein abundance compared with control group. |
RING finger protein 1 (RNF1) |
Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s)
|
Detailed Information |
Protein Info
click to show the details of this protein
|
Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] |
Introduced Variation |
Glutamine absence (16 hours) |
Induced Change |
E3 ubiquitin-protein ligase RING1 protein abundance levels: increase (FC = 1.38) |
Summary |
Introduced Variation
Induced Change
|
Disease Status |
Hepatocellular carcinoma [ICD-11: 2C12]
|
Details |
It is reported that glutamine absence causes the increase of E3 ubiquitin-protein ligase RING1 protein abundance compared with control group. |
|
|
|
|
|
|
|